Bone Regeneration With Mesenchymal Stem Cells
Primary Purpose
Mandibular Fractures
Status
Completed
Phase
Phase 3
Locations
Study Type
Interventional
Intervention
Application of autologous mesenchymal stem cells
Sponsored by
About this trial
This is an interventional treatment trial for Mandibular Fractures focused on measuring Mesenchymal Stem Cells, Treatment
Eligibility Criteria
Inclusion Criteria:
- Entitled patients to the Mexican Institute of Social Security
- Patients with mandibular condyle fractures associated or not to other initial fracture that required Open reduction and internal fixation
- Ages from 17 to 59 years
- Both female and male gender
- Patients who gave their consent to be part of this trial
Exclusion Criteria:
- Patients younger than 17 years and older than 59 years
- Chronic-degenerative diseases, active smoking, collagen disorders
- Patients with signs of infection in the aimed area to treat and in whom the fracture occurred in a longer period than 10 days before their surgery.
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
No Intervention
Arm Label
Fractures with Mesenchymal Stem Cells
Fractures without Mesenchymal Stem Cells
Arm Description
10 patients with mandibular fractures were managed by open reduction and internal fixation, with application of autologous mesenchymal stem cells on the fracture site.
10 patients with mandibular fractures were managed by open reduction and internal fixation, without application of autologous mesenchymal stem cells on the fracture site.
Outcomes
Primary Outcome Measures
Change of bone quality
After the procedure, imaging control by X-ray and analysis by software, was done after surgery at weeks 4 and 12. X- ray units: Voxels. Software analysis by Image Processing and Analysis ImageJ 1.43
Change of bone quality
After the procedure, imaging control by CT scan and analysis by software, was done after surgery at weeks 4 and 12. CT scan units: Hounsfiled . Software analysis by Image Processing and Analysis ImageJ 1.43
Secondary Outcome Measures
Number of patients with infection ( increase of local temperature, tenderness, leukocyte count >10,000/ µL, confirmed by Gram stain and blood culture).
Infection suggested by clinical diagnosis increase of leukocyte levels, and confirmed by Gram stain and blood culture of local sample.
Number of patients with bleeding after surgery (Persistent bleeding, ineffectiveness stopping bleeding using dressings)
Persistent bleeding after surgery, that did not stop by dressings. If this complication developed, it had to be managed by surgical techniques.
Number of patients with surgical wound dehiscence (subcutaneous tissue , bone or osteosynthesis material exposed and seen through opened skin )
Clinical signs of dehiscence on the surgical incision, surgical material or bone seen though the skin. This diagnosis is done by clinical findings. Does not need any laboratory or image test.
Full Information
NCT ID
NCT02755922
First Posted
April 20, 2016
Last Updated
April 26, 2016
Sponsor
Instituto Mexicano del Seguro Social
1. Study Identification
Unique Protocol Identification Number
NCT02755922
Brief Title
Bone Regeneration With Mesenchymal Stem Cells
Official Title
Bone Regeneration in Mandibular Fractures After the Application of Autologous Mesenchymal Stem Cells. Randomized Clinical Trial.
Study Type
Interventional
2. Study Status
Record Verification Date
April 2016
Overall Recruitment Status
Completed
Study Start Date
April 2010 (undefined)
Primary Completion Date
September 2010 (Actual)
Study Completion Date
December 2010 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Instituto Mexicano del Seguro Social
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
Mandible fractures are a common cause of facial injury in adults. The autologous mesenchymal stem cell (AMSC) transplantation, is proposed as an alternative to the conventional graft treatment, improving bone neoformation.The objective was to evaluate the effectiveness of AMSCs application in mandibular fractures to reduce regeneration time and increase bone quality.
Detailed Description
Single blinded controlled clinical trial in patients with mandibular angle fracture. The patients were divided into: Study Group (SG): fracture reduction plus application of AMSCs, Control Group (CG): Same procedure without AMSCs. AMSCs were obtained from adipose tissue , 24 hrs before the procedure. Intensity and density were evaluated in normal bone and fractured bone, at 4 and 12 weeks after surgery using panoramic radiography and computed tomography. (CT)
A total of 20 patients, 10 in each group were included. SG with a mean age of 31.2 ± 6.3 years and CG 29.7 ± 7.2 years, all patients were male. Bone quality at week 4 SG 108.82 ± 3.4 vs CG 93.92 ± 2.6 (p = 0.000) by panoramic radiography, SG 123 ± 4.53 vs CG 99.72 ± 5.72 (p = 0.000) by CT. At week 12: SG 153.53±1.83 vs CG 101.81±4.83 (p= 0.000) by panoramic radiography, SG 165.4 ± 4.2 vs CG 112.05±2.1 (p= 0.000) by CT.
The application of AMSCs presented at week 4 similar ossification values compared with normal bone and a 36.48 % higher ossification rate at week 12.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Mandibular Fractures
Keywords
Mesenchymal Stem Cells, Treatment
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
20 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Fractures with Mesenchymal Stem Cells
Arm Type
Experimental
Arm Description
10 patients with mandibular fractures were managed by open reduction and internal fixation, with application of autologous mesenchymal stem cells on the fracture site.
Arm Title
Fractures without Mesenchymal Stem Cells
Arm Type
No Intervention
Arm Description
10 patients with mandibular fractures were managed by open reduction and internal fixation, without application of autologous mesenchymal stem cells on the fracture site.
Intervention Type
Biological
Intervention Name(s)
Application of autologous mesenchymal stem cells
Intervention Description
within the surgical procedure, mesenchymal stem cells, were applied on the fracture site. Imaging by X-ray and CT and imaging analysis was done after fracture repair, at week 4 and week 12
Primary Outcome Measure Information:
Title
Change of bone quality
Description
After the procedure, imaging control by X-ray and analysis by software, was done after surgery at weeks 4 and 12. X- ray units: Voxels. Software analysis by Image Processing and Analysis ImageJ 1.43
Time Frame
from the moment of fracture diagnosis to week 4 and week 12 after surgery
Title
Change of bone quality
Description
After the procedure, imaging control by CT scan and analysis by software, was done after surgery at weeks 4 and 12. CT scan units: Hounsfiled . Software analysis by Image Processing and Analysis ImageJ 1.43
Time Frame
from the moment of fracture diagnosis to week 4 and week 12 after surgery
Secondary Outcome Measure Information:
Title
Number of patients with infection ( increase of local temperature, tenderness, leukocyte count >10,000/ µL, confirmed by Gram stain and blood culture).
Description
Infection suggested by clinical diagnosis increase of leukocyte levels, and confirmed by Gram stain and blood culture of local sample.
Time Frame
from immediate postoperative period to three months after surgery
Title
Number of patients with bleeding after surgery (Persistent bleeding, ineffectiveness stopping bleeding using dressings)
Description
Persistent bleeding after surgery, that did not stop by dressings. If this complication developed, it had to be managed by surgical techniques.
Time Frame
from immediate postoperative period to 1 week after surgery
Title
Number of patients with surgical wound dehiscence (subcutaneous tissue , bone or osteosynthesis material exposed and seen through opened skin )
Description
Clinical signs of dehiscence on the surgical incision, surgical material or bone seen though the skin. This diagnosis is done by clinical findings. Does not need any laboratory or image test.
Time Frame
from immediate postoperative period to one month
10. Eligibility
Sex
All
Minimum Age & Unit of Time
17 Years
Maximum Age & Unit of Time
59 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Entitled patients to the Mexican Institute of Social Security
Patients with mandibular condyle fractures associated or not to other initial fracture that required Open reduction and internal fixation
Ages from 17 to 59 years
Both female and male gender
Patients who gave their consent to be part of this trial
Exclusion Criteria:
Patients younger than 17 years and older than 59 years
Chronic-degenerative diseases, active smoking, collagen disorders
Patients with signs of infection in the aimed area to treat and in whom the fracture occurred in a longer period than 10 days before their surgery.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Alejandro Gonzalez Ojeda, M.D., Ph.D.
Organizational Affiliation
Instituto Mexicano del Seguro Social
Official's Role
Principal Investigator
12. IPD Sharing Statement
Plan to Share IPD
Yes
Learn more about this trial
Bone Regeneration With Mesenchymal Stem Cells
We'll reach out to this number within 24 hrs